Cure My Disease

Don't miss your cure!

 Log in / Sign up

Drug safety check for breast cancer patients after surgery

NCT ID NCT05677308

Completed Disease control Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

Summary

This study monitored the safety of LYNPARZA, a medication given after surgery to help prevent breast cancer from returning in high-risk patients. Researchers tracked 61 patients with specific genetic mutations to see how often they experienced bone marrow suppression, a known side effect that can affect blood cell counts. The goal was to understand the real-world safety profile of this already-approved treatment.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Research Site

    Aichi, Japan

  • Research Site

    Akita, Japan

  • Research Site

    Aomori, Japan

  • Research Site

    Chiba, Japan

  • Research Site

    Ehime, Japan

  • Research Site

    Fukui, Japan

  • Research Site

    Fukuoka, Japan

  • Research Site

    Gifu, Japan

  • Research Site

    Gunma, Japan

  • Research Site

    Hiroshima, Japan

  • Research Site

    Hokkaido, Japan

  • Research Site

    Hyōgo, Japan

  • Research Site

    Ibaraki, Japan

  • Research Site

    Ishikawa, Japan

  • Research Site

    Kanagawa, Japan

  • Research Site

    Kochi, Japan

  • Research Site

    Kumamoto, Japan

  • Research Site

    Kyoto, Japan

  • Research Site

    Mie, Japan

  • Research Site

    Miyagi, Japan

  • Research Site

    Nara, Japan

  • Research Site

    Niigata, Japan

  • Research Site

    Numakunai, Japan

  • Research Site

    Okayama, Japan

  • Research Site

    Okinawa, Japan

  • Research Site

    Osaka, Japan

  • Research Site

    Ōita, Japan

  • Research Site

    Saga, Japan

  • Research Site

    Saitama, Japan

  • Research Site

    Shiga, Japan

  • Research Site

    Shimane, Japan

  • Research Site

    Shizuoka, Japan

  • Research Site

    Tochigi, Japan

  • Research Site

    Tokyo, Japan

  • Research Site

    Tottori, Japan

  • Research Site

    Toyama, Japan

  • Research Site

    Wakayama, Japan

  • Research Site

    Yamaguchi, Japan

Conditions

Explore the condition pages connected to this study.

BREAST CANCER